Education
About Us
Working with TipRanks
Follow Us
Instil Bio (TIL)
NASDAQ:TIL
Total Valuation
Instil Bio has a market cap or net worth of $143.86M. The enterprise value is $117.78M.
Market Cap$143.86M
Enterprise Value$117.78M
Share Statistics
Instil Bio has 6,559,927 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,559,927
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Instil Bio’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -28.58%.
Return on Equity (ROE)-0.44
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-28.58%
Return on Capital Employed (ROCE)-0.29
Revenue Per Employee0.00
Profits Per Employee-5.30M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Instil Bio is -1.68. Instil Bio’s PEG ratio is >-0.01.
PE Ratio-1.68
PS Ratio0.00
PB Ratio0.22
Price to Fair Value0.73
Price to FCF-0.31
Price to Operating Cash Flow-0.45
PEG Ratio>-0.01
Income Statement
In the last 12 months, Instil Bio had revenue of 0.00 and earned -74.14M in profits. Earnings per share was -11.39.
Revenue0.00
Gross Profit0.00
Operating Income-73.54M
Pretax Income-74.14M
Net Income-74.14M
EBITDA-61.53M
Earnings Per Share (EPS)-11.39
Cash Flow
In the last 12 months, operating cash flow was -55.70M and capital expenditures 0.00, giving a free cash flow of -55.70M billion.
Operating Cash Flow-55.70M
Free Cash Flow-55.70M
Free Cash Flow per Share-8.49
Dividends & Yields
Instil Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta4.58
52-Week Price Change132.97%
50-Day Moving Average22.47
200-Day Moving Average26.74
Relative Strength Index (RSI)45.83
Average Volume (3m)437.79K
Important Dates
Instil Bio upcoming earnings date is Aug 8, 2025, Before Open (Confirmed).
Last Earnings DateMay 13, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend Date―
Financial Position
Instil Bio as a current ratio of 15.76, with Debt / Equity ratio of 21.97%
Current Ratio15.76
Quick Ratio15.76
Debt to Market Cap0.68
Net Debt to EBITDA-1.27
Interest Coverage Ratio-8.18
Taxes
In the past 12 months, Instil Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Instil Bio EV to EBITDA ratio is -3.29, with an EV/FCF ratio of -3.63.
EV to Sales0.00
EV to EBITDA-3.29
EV to Free Cash Flow-3.63
EV to Operating Cash Flow-3.63
Balance Sheet
Instil Bio has $113.31M in cash and marketable securities with $86.89M in debt, giving a net cash position of -$26.43M billion.
Cash & Marketable Securities$113.31M
Total Debt$86.89M
Net Cash-$26.43M
Net Cash Per Share-$4.03
Tangible Book Value Per Share$26.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Instil Bio is $125.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$125.00
Price Target Upside470.00% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast52.54%